News

Last year’s numbers indicate historic lows

$180M collaboration aims to introduce multiple vaccine candidates in 2022

Two-dose COVAXIN currently under EUA in India

Rating for packaging supplier highlights its commitment to sustainable practices and corporate social responsibility

CDMO to take over operations, including equipment and workforce, at site in Couvet, Switzerland

Deal completes Verista's lifecycle support for pharma, which now includes consulting, technology and manufacturing

Agreement provides Acentrus with specialty pharmacy accreditation

Following last week's announcement of supply decrease, company raises projection by 9 million

In Phase III at the moment, mRNA dose will be produced at Bayer's Wuppertal, Germany facility

Production expected to begin in the second quarter

Pharmacy associations seek involvement in vaccinating long-term care sector

Technology designed specifically for allogeneic cell therapy workflows

Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another

Forms three new business units to integrate healthcare services

Komodo-BHI agreement grows patient database to 325M

In alternative to traditional data logging, company launches sensor targeting quick and safe vaccine storage

Technology partnership focused on improving patient-level data integration

Terms provide equitable access to Covid-19 vaccine

Cold-chain deal strives to contribute to vaccine distribution efforts

Powered by AI analytics, healthcare partnership aims to increase member engagement

Boston-area location will be fully operational in Q4

Latest air cargo collaboration provides pandemic response support

GlobalData predicts that RPM will be the prevailing industry trend in 2021

Acquisition of point-of-care diagnostics provider could reach upwards of $550M

Alliance strives to develop novel AAV vectors

Collaboration focuses on condition-specific support and engagement

Aims to replicate the logistics of on-site testing sites to create "micro-to-mega" vaccination sites

Secures $76M in funding for Boston-area manufacturing and innovation center